I would like to ask.
In the quarterly report for the period ending December 2016, the company stated that:
' Alexium expects US Defense sector FR uniforms treated with AlexiflamTM to be a significant contributor to the Company’s top-line revenue model in 2017'
Does the company still expect this to be the case?
And if not,why not?what has changed/happened/not happened since the 31st of Jan.
Cheers.
Thread for shareholder questions for Dirk and Bob, page-7
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
